Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. Definium develops science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, the company has been powered by a radical idea: treatments for anxiety and depression should bring real relief. Definium is moving psychiatry forward — beyond better, into a boundless future.
